Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #3684582

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
466,000 EUR
468,000 EUR
Cash flows from (used in) operations before changes in working capital
2 764 EUR
1 491 EUR
Adjustments for decrease (increase) in trade and other receivables
335,000 EUR
1 094 EUR
Adjustments for increase (decrease) in trade and other payables
688,000 EUR
75,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
2 499 EUR
2 193 EUR
Finance costs paid, classified as operating activities
121,000 EUR
93,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
553,000 EUR
318,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.